{"2502.06289": {"publish_time": "2025-02-10", "title": "Is an Ultra Large Natural Image-Based Foundation Model Superior to a Retina-Specific Model for Detecting Ocular and Systemic Diseases?", "paper_summary": "The advent of foundation models (FMs) is transforming medical domain. In\nophthalmology, RETFound, a retina-specific FM pre-trained sequentially on 1.4\nmillion natural images and 1.6 million retinal images, has demonstrated high\nadaptability across clinical applications. Conversely, DINOv2, a\ngeneral-purpose vision FM pre-trained on 142 million natural images, has shown\npromise in non-medical domains. However, its applicability to clinical tasks\nremains underexplored. To address this, we conducted head-to-head evaluations\nby fine-tuning RETFound and three DINOv2 models (large, base, small) for ocular\ndisease detection and systemic disease prediction tasks, across eight\nstandardized open-source ocular datasets, as well as the Moorfields AlzEye and\nthe UK Biobank datasets. DINOv2-large model outperformed RETFound in detecting\ndiabetic retinopathy (AUROC=0.850-0.952 vs 0.823-0.944, across three datasets,\nall P<=0.007) and multi-class eye diseases (AUROC=0.892 vs. 0.846, P<0.001). In\nglaucoma, DINOv2-base model outperformed RETFound (AUROC=0.958 vs 0.940,\nP<0.001). Conversely, RETFound achieved superior performance over all DINOv2\nmodels in predicting heart failure, myocardial infarction, and ischaemic stroke\n(AUROC=0.732-0.796 vs 0.663-0.771, all P<0.001). These trends persisted even\nwith 10% of the fine-tuning data. These findings showcase the distinct\nscenarios where general-purpose and domain-specific FMs excel, highlighting the\nimportance of aligning FM selection with task-specific requirements to optimise\nclinical performance.", "paper_summary_zh": "\u57fa\u790e\u6a21\u578b (FM) \u7684\u51fa\u73fe\u6b63\u5728\u8f49\u8b8a\u91ab\u7642\u9818\u57df\u3002\u5728\u773c\u79d1\uff0cRETFound \u662f\u4e00\u500b\u8996\u7db2\u819c\u5c08\u7528 FM\uff0c\u4f9d\u5e8f\u4f7f\u7528 140 \u842c\u5f35\u81ea\u7136\u5f71\u50cf\u548c 160 \u842c\u5f35\u8996\u7db2\u819c\u5f71\u50cf\u9032\u884c\u9810\u8a13\u7df4\uff0c\u5df2\u5c55\u73fe\u51fa\u9ad8\u5ea6\u9069\u61c9\u6027\uff0c\u53ef\u61c9\u7528\u65bc\u5404\u7a2e\u81e8\u5e8a\u61c9\u7528\u3002\u76f8\u53cd\u5730\uff0cDINOv2 \u662f\u4e00\u500b\u901a\u7528\u8996\u89ba FM\uff0c\u4f7f\u7528 1.42 \u5104\u5f35\u81ea\u7136\u5f71\u50cf\u9032\u884c\u9810\u8a13\u7df4\uff0c\u5df2\u5c55\u73fe\u51fa\u5728\u975e\u91ab\u7642\u9818\u57df\u7684\u6f5b\u529b\u3002\u7136\u800c\uff0c\u5176\u5728\u81e8\u5e8a\u4efb\u52d9\u4e2d\u7684\u9069\u7528\u6027\u4ecd\u672a\u88ab\u5145\u5206\u63a2\u7d22\u3002\u70ba\u4e86\u89e3\u6c7a\u9019\u500b\u554f\u984c\uff0c\u6211\u5011\u91dd\u5c0d\u773c\u90e8\u75be\u75c5\u5075\u6e2c\u548c\u5168\u8eab\u6027\u75be\u75c5\u9810\u6e2c\u4efb\u52d9\uff0c\u5c0d RETFound \u548c\u4e09\u500b DINOv2 \u6a21\u578b\uff08\u5927\u578b\u3001\u57fa\u790e\u3001\u5c0f\u578b\uff09\u9032\u884c\u5fae\u8abf\uff0c\u4e26\u9032\u884c\u4e00\u5c0d\u4e00\u7684\u8a55\u4f30\uff0c\u4f7f\u7528\u516b\u500b\u6a19\u6e96\u5316\u7684\u958b\u6e90\u773c\u79d1\u8cc7\u6599\u96c6\uff0c\u4ee5\u53ca Moorfields AlzEye \u548c UK Biobank \u8cc7\u6599\u96c6\u3002DINOv2 \u5927\u578b\u6a21\u578b\u5728\u7cd6\u5c3f\u75c5\u8996\u7db2\u819c\u75c5\u8b8a\u5075\u6e2c\u65b9\u9762\u512a\u65bc RETFound\uff08\u4e09\u500b\u8cc7\u6599\u96c6\u7684 AUROC=0.850-0.952\uff0c\u76f8\u8f03\u65bc 0.823-0.944\uff0c\u6240\u6709 P<=0.007\uff09\u548c\u591a\u985e\u773c\u90e8\u75be\u75c5\uff08AUROC=0.892\uff0c\u76f8\u8f03\u65bc 0.846\uff0cP<0.001\uff09\u3002\u5728\u9752\u5149\u773c\u65b9\u9762\uff0cDINOv2 \u57fa\u790e\u6a21\u578b\u512a\u65bc RETFound\uff08AUROC=0.958\uff0c\u76f8\u8f03\u65bc 0.940\uff0cP<0.001\uff09\u3002\u76f8\u53cd\u5730\uff0cRETFound \u5728\u9810\u6e2c\u5fc3\u81df\u8870\u7aed\u3001\u5fc3\u808c\u6897\u585e\u548c\u7f3a\u8840\u6027\u4e2d\u98a8\u65b9\u9762\u512a\u65bc\u6240\u6709 DINOv2 \u6a21\u578b\uff08AUROC=0.732-0.796\uff0c\u76f8\u8f03\u65bc 0.663-0.771\uff0c\u6240\u6709 P<0.001\uff09\u3002\u5373\u4f7f\u4f7f\u7528 10% \u7684\u5fae\u8abf\u8cc7\u6599\uff0c\u9019\u4e9b\u8da8\u52e2\u4ecd\u7136\u6301\u7e8c\u3002\u9019\u4e9b\u767c\u73fe\u5c55\u793a\u4e86\u901a\u7528\u548c\u9818\u57df\u5c08\u7528 FM \u5404\u81ea\u64c5\u9577\u7684\u5834\u666f\uff0c\u7a81\u986f\u4e86\u6839\u64da\u4efb\u52d9\u7279\u5b9a\u9700\u6c42\u8abf\u6574 FM \u9078\u64c7\uff0c\u4ee5\u6700\u4f73\u5316\u81e8\u5e8a\u8868\u73fe\u7684\u91cd\u8981\u6027\u3002", "author": "Qingshan Hou et.al.", "authors": "Qingshan Hou, Yukun Zhou, Jocelyn Hui Lin Goh, Ke Zou, Samantha Min Er Yew, Sahana Srinivasan, Meng Wang, Thaddaeus Lo, Xiaofeng Lei, Siegfried K. Wagner, Mark A. Chia, Dawei Yang, Hongyang Jiang, AnRan Ran, Rui Santos, Gabor Mark Somfai, Juan Helen Zhou, Haoyu Chen, Qingyu Chen, Carol Yim-Lui Cheung, Pearse A. Keane, Yih Chung Tham", "id": "2502.06289v1", "paper_url": "http://arxiv.org/abs/2502.06289v1", "repo": "null"}}